157 related articles for article (PubMed ID: 2807727)
1. Conformation and complexation with metal ions of cyclic hexapeptides: cyclo (L-Leu-L-Phe-L-Pro)2 and cyclo [L-Cys(Acm)-L-Phe-L-Pro]2.
Ozeki E; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):111-7. PubMed ID: 2807727
[TBL] [Abstract][Full Text] [Related]
2. Cyclic hexapeptides bearing carboxyl groups. Interaction with metal ions and lipid membrane.
Ozeki E; Miyazu T; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):97-103. PubMed ID: 2807735
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and interaction with metal ions of cyclic oligopeptides bearing carboxyl groups.
Fusaoka Y; Ozeki E; Kimura S; Imanishi Y
Int J Pept Protein Res; 1989 Aug; 34(2):104-10. PubMed ID: 2807726
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and backbone conformations of cyclic hexapeptides cyclo-(Xxx-Pro-D-Gln)2.
Kopple KD; Parameswaran KN
Int J Pept Protein Res; 1983 Mar; 21(3):269-80. PubMed ID: 6853028
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
6. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 13C nuclear magnetic resonance.
Ishizu T; Fujii A; Noguchi S
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1617-9. PubMed ID: 1934186
[TBL] [Abstract][Full Text] [Related]
7. Structure of cyclic peptides: the crystal and solution conformation of cyclo(Phe-Phe-Aib-Leu-Pro).
Zanotti G; Saviano M; Saviano G; Tancredi T; Rossi F; Pedone C; Benedetti E
J Pept Res; 1998 Jun; 51(6):460-6. PubMed ID: 9650721
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ binding cyclic octapeptides having an alternating Sar and a hydrophobic amino acid in the sequence.
Kimura S; Ozeki E; Imanishi Y
Biopolymers; 1989 Jul; 28(7):1235-46. PubMed ID: 2775838
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
11. Structure and conformations of two cycloisomeric hexapeptides: cyclo(L-Leu-L-Phe-Gly-D-Phe-L-Leu-Gly-) trihydrate and cyclo(L-Phe-L-Leu-Gly-D-Leu-L-Phe-Gly-) trihydrate.
Barnes CL; Hossain MB; Fidelis K; van der Helm D
Acta Crystallogr B; 1990 Apr; 46 ( Pt 2)():238-46. PubMed ID: 2344396
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ transport through lipid membrane by diastereomer cyclic octapeptides.
Kimura S; Ozeki E; Imanishi Y
Biopolymers; 1989 Jul; 28(7):1247-57. PubMed ID: 2775839
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
Ishizu T; Fujii A; Noguchi S
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
[TBL] [Abstract][Full Text] [Related]
14. Conformational behaviour of a cyclolinopeptide A analogue: two-dimensional NMR study of cyclo(Pro1-Pro-Phe-Phe-Ac6c-Ile-ala-Val8).
Mazzeo M; Isernia C; Rossi F; Saviano M; Pedone C; Paolillo L; Benedetti E; Pavone V
J Pept Sci; 1995; 1(5):330-40. PubMed ID: 9223012
[TBL] [Abstract][Full Text] [Related]
15. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
Jois DS; Easwaran KR; Bednarek M; Blout ER
Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanics investigation of the flexibility of some cyclic peptides.
Romanowska K; Kopple KD
Int J Pept Protein Res; 1987 Sep; 30(3):289-98. PubMed ID: 3692678
[TBL] [Abstract][Full Text] [Related]
17. Conformations of cyclo(L-orD-Phe-L-Pro-Aca) and cyclo(L-Pro-L- or D-Phe-Aca). Cyclized dipeptide models for specific types of beta-bends.
Mizuno H; Lee S; Nakamura H; Kodera Y; Kato T; Go N; Izumiya N
Biophys Chem; 1986 Nov; 25(1):73-90. PubMed ID: 3814747
[TBL] [Abstract][Full Text] [Related]
18. Ion binding of cyclolinopeptide A: an NMR and CD conformational study.
Tancredi T; Benedetti E; Grimaldi M; Pedone C; Rossi F; Saviano M; Temussi PA; Zanotti G
Biopolymers; 1991 May; 31(6):761-7. PubMed ID: 1932572
[TBL] [Abstract][Full Text] [Related]
19. Complex formation of cyclo(L-Phe-L-Pro)4 with noradrenaline hydrochloride.
Ishizu T; Hirayama J; Noguchi S
Chem Pharm Bull (Tokyo); 1994 May; 42(5):1146-8. PubMed ID: 8069966
[TBL] [Abstract][Full Text] [Related]
20. [Cyclic analogs of substance P. III. Cyclo (6(sup)gamma----oligomethylenediamine----11) substance P(6-11)-hexapeptides].
Mutulis FK; Mutule IE; Maurops GKh; Bergmann Iu; Myshliakova NV; Strazda GM; Liepin'sh EE; Saulitis IuB; Grigor'eva VD; Balodis IuIu
Bioorg Khim; 1991 Oct; 17(10):1412-23. PubMed ID: 1725106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
